Exosomal miR-140-3p and miR-143-3p from TGF-β1-treated pancreatic stellate cells target BCL2 mRNA to increase β-cell apoptosis

By rosaguerrero • May 2, 2022

Zhu X, Liu D, Li G, Zhi M, Sun J, Qi L, Li J, Pandol SJ, Li L. Exosomal miR-140-3p and miR-143-3p from TGF-β1-treated pancreatic stellate cells target BCL2 mRNA to increase β-cell apoptosis. Mol Cell Endocrinol. 2022 May 2;551:111653. doi: 10.1016/j.mce.2022.111653. Epub ahead of print. PMID: 35513284.

Tags: Digestive Diseases, Publications

Actionable Clinical Features and Biomarkers to Facilitate the Management of Irritable Bowel Syndrome

Shin A, Staller K, Levinthal DJ. Actionable Clinical Features and Biomarkers to Facilitate the Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2025 Nov 19.[...]

Nationwide Analysis of Food Insecurity among Individuals with Inflammatory Bowel Disease in the United States

Baniqued MR, Greb AC, Shah ND, Parian AA, Li Z, Limketkai BN. Nationwide Analysis of Food Insecurity among Individuals with Inflammatory Bowel Disease in the[...]

Increasing timely colonoscopy surveillance for patients with high-risk colorectal polyps: Protocol for a cluster randomized trial

May FP, McEwan JA, Tuan JJ, Crespi CM, Maehara CK, Yang JO, Uy A, Gupta S, Kang Y, Myint A, Naini BV, Elmore JG, Kadiyala[...]